Page
%P
-
Article
Open AccessComparative Economics of a 12-Gene Assay for Predicting Risk of Recurrence in Stage II Colon Cancer
Prior economic analysis that compared the 12-gene assay to published patterns of care predicted the assay would improve outcomes while lowering medical costs for stage II, T3, mismatch-repair-proficient (MMR-P...